CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $89,088
- in 5 filings, $89K under 10b5-1 plans
Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-18 | Myer Vickesh Chief Technology Officer | Option exercise | +3,000 | $0.65 | $2K | 3,000 |
| 2019-03-18 | Myer Vickesh Chief Technology Officer | Sale | −3,000 | $24.50 | $74K | 0 |
| 2019-03-18 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −3,000 | 73,307 | ||
| 2019-02-20 | Myer Vickesh Chief Technology Officer | Option exercise | +3,000 | $0.65 | $2K | 3,000 |
| 2019-02-20 | Myer Vickesh Chief Technology Officer | Sale | −3,000 | $20.42 | $61K | 0 |
| 2019-02-20 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −3,000 | 76,307 | ||
| 2019-02-06 | Myer Vickesh Chief Technology Officer | Grant or award · Stock Option (right to buy) | +48,750 | 48,750 | ||
| 2019-02-06 | Myer Vickesh Chief Technology Officer | Grant or award · Restricted Stock Units | +8,125 | 8,125 | ||
| 2019-01-31 | Myer Vickesh Chief Technology Officer | Grant or award · Restricted Stock Units | +16,722 | 16,722 | ||
| 2019-01-18 | Myer Vickesh Chief Technology Officer | Option exercise | +4,000 | $11.21 | $45K | 4,000 |
| 2019-01-18 | Myer Vickesh Chief Technology Officer | Sale | −4,000 | $26.50 | $106K | 0 |
| 2019-01-18 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −4,000 | 52,897 | ||
| 2019-01-17 | Myer Vickesh Chief Technology Officer | Option exercise | +3,000 | $0.65 | $2K | 3,000 |
| 2019-01-17 | Myer Vickesh Chief Technology Officer | Sale | −3,000 | $26.18 | $79K | 0 |
| 2019-01-17 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −3,000 | 79,307 | ||
| 2018-12-18 | Myer Vickesh Chief Technology Officer | Option exercise | +4,000 | $11.21 | $45K | 4,000 |
| 2018-12-18 | Myer Vickesh Chief Technology Officer | Sale | −4,000 | $27.41 | $110K | 0 |
| 2018-12-18 | Myer Vickesh Chief Technology Officer | Option exercise · Stock Option (right to buy) | −4,000 | 56,897 | ||
| 2018-12-17 | Myer Vickesh Chief Technology Officer | Option exercise | +3,000 | $0.65 | $2K | 3,000 |
| 2018-12-17 | Myer Vickesh Chief Technology Officer | Sale | −2,300 | $27.75 | $64K | 700 |
Page 1 of 4 · 68 trades